Women’s experiences of gynaecological surveillance in Lynch syndrome
Gynaecological surveillance is offered in Lynch syndrome despite limited evidence for its clinical effectiveness. Invasive gynaecological investigations often cause pain and distress, but experiences vary and little is known about the psychological burden of repeated testing. We evaluated the lived experiences of annual gynaecological surveillance in women with and at risk of Lynch syndrome. Recruitment occurred via hospital clinics, social media, and Lynch Syndrome UK. Participants completed a semi-structured questionnaire by telephone. Quantitative data were summarised descriptively. Free-text responses were recorded verbatim, coded inductively and grouped thematically, with outputs reviewed by a second researcher. Overall, 104 women participated: 93 had confirmed Lynch syndrome and 11 had a strong family history of Lynch syndrome cancers (median age: 41 years). Median pain scores were 7/10 for outpatient hysteroscopy (IQR 6–9) and endometrial biopsy (IQR 6–10), versus 3/10 for pelvic examination and transvaginal ultrasound scan (both IQR 2–4). Among participants undergoing annual surveillance (75/104), 74 (98.6%) found surveillance reassuring, but 44 (58.6%) reported surveillance-related anxiety. 51 (68%) said they attended all scheduled surveillance visits. Free-text responses identified anticipatory procedural distress and cancer worry, particularly fear of adverse findings. Participants described surveillance as necessary given the limited non-surgical alternatives. Although regular gynaecological surveillance provides reassurance, it imposes considerable physical, psychological and practical burdens. Addressing this requires a dual approach: immediate optimisation of pain management and psychological support within current clinics, alongside a long-term shift toward non-invasive diagnostic innovations to fundamentally transform the healthcare experiences of high-risk cohorts.
Authors
- Srdjan Saso (ORCID: https://orcid.org/0000-0002-6310-032X)
- Molly Dore
- Kevin John Monahan (ORCID: https://orcid.org/0000-0002-7918-4003)
- Jean-Ellen Johnson (ORCID: https://orcid.org/0000-0001-9606-361X)
- Tracy Smith
- Emma Davidson
- Janos Balega
- Tim Duncan
Institutions
- Sandwell & West Birmingham Hospitals NHS Trust (GB)
- Manchester Academic Health Science Centre (GB)
- Norfolk and Norwich University Hospitals NHS Foundation Trust (GB)
- Edinburgh Cancer Research (GB)
- University of Manchester (GB)
- St Mary's Hospital (GB)
- Manchester University NHS Foundation Trust (GB)
- St. Mark's Hospital (US)
- MRC Centre for Reproductive Health (GB)
- Institute of Genetics and Cancer (GB)
- St Mark's Hospital (GB)
- Imperial College London (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- Familial Cancer
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s10689-026-00619-3
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00